Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial

2015

Lancet Oncology, The - In Press.Proof corrected by the author Available online since mercredi 4 fevrier 2015

Keywords:

References

Citations